Microbial biotechnology

Cards (73)

  • Clone
    cDNA piece inserted into a vector which expresses it
  • Types of libraries
    • cDNA
    • Genomic
  • cDNA is used to express a given protein
  • How to produce cDNA from mRNA
    1. ssDNA production
    2. RNA degradation
    3. dsDNA production
    4. Termination
  • How to produce a cDNA library
    1. isolate and collect mRNA from sample
    2. Use reverse transcription to produce a double-stranded cDNA
    3. Ligate into plasmid
    4. Transform into bacterial cell
    5. culture
    6. plasmid isolation and purification
  • 3 methods to screen cDNA libraries
    • Hybridization (using labelled probes)
    • Immunodetection (using antibodies)
    • Complementation (using mutants)
  • Hybridization probe
    DNA (or RNA) fragment, usually 100-1000 bases, specific to target cDNA sequence, labelled
  • Homology probe
    The probe carries the corresponding DNA sequence from a related organism
  • Degenerate oligonucleotides
    The probe carries a degenerated DNA sequence inferred from a known PROTEIN sequence
  • How to design degenerate oligonucleotides
    Choose all possible cDNA sequences that codes for that protein
    Choose a sequence that has the fewest number of possibilities, shorter sequence
  • Radioactive labels
    Incorporation of nucleotides containing radioactive phosphorus (32P or 33P)
  • Non-radioactive labels
    Incorporation of nucleotides coupled to digoxygenin (DIG)
  • Incorporating labels into DNA
    Using terminal transferase or Taq polymerase
  • Immunodetection: clone identification using antibodies

    Make the cDNA clone produce protein, produce an antibody recognising this protein, the clone of interest is where the antibody binds
  • How to produce specific antibodies
    Take gene of interest, immunisation of animal, tumour cells fused, forming a hybridomas, screened for desired antibody, selected antibody is mass produced
  • How to make cDNA clones produce proteins
    cDNA in phage, infect E. coli, E. coli replicates phage and produces the protein, phage kills E. coli, which releases the protein
  • Nitrocellulose
    Binds to any protein
  • Immunodetection screening
    Label primary antibody, label secondary antibody that recognize the primary antibody
  • Complementation screening
    Use the activity of the protein to rescue the corresponding mutant
  • Recombinant proteins
    • Insulin
    • Tissue Plasminogen Activator (tPA)
    • Human growth hormone (hGH)
    • Factor VII
    • Granulocyte Colony Stimulating Factor (G-CSF)
    • Erythropoietin (EPO)
    • Vaccine proteins
  • Uses of recombinant proteins
    • Management of blood sugar levels (diabetes)
    • Dissolving blood clots, pulmonary embolism, heart attack
    • Short stature/hGH deficiency
    • Haemophilia
    • Boosting white blood cells (infections, chemotherapy)
    • Anaemia, chronic kidney failure, doping (cyclists)
    • Immunisation against bacteria or viruses
    • Disease management
  • Important considerations for expression system
    Size of the target protein, Solubility of the target protein, Post-translational modifications
  • Genetic optimization for E.coli protein expression
    • Enhancing the codon usage to match E.coli preferred codons
    • Optimizing promotor and operator sequences for stronger expression
  • Why E. coli?

    Simple, cheap, and fast to grow, genetics (many strains and mutants available), high yield (high-copy plasmids: many DNA templates per cell)
  • What can be optimised?
    • The E. coli strain
    • The plasmid vector
    • The coding cDNA sequence
  • Considerations when choosing expression system
    • Size of the target protein
    • Solubility of the target protein
    • Post-translational modifications required
  • Bacteria won't produce very large molecules or protein complexes, CHO cells would
  • Membrane proteins won't be easily recovered from bacteria, a eukaryotic system may be necessary
  • Bacteria cannot perform some post-translational modifications like glycosylation, porcine cells are favoured for human proteins because they use similar sugar groups
  • Genetic optimization for E.coli protein expression
    • Enhancing the codon usage to match E.coli preferred codons
    • Optimizing promotor and operator sequences for stronger expression
  • What can be optimised for E. coli expression
    • The E. coli strain
    • The plasmid vector
    • The coding cDNA sequence inserted
  • Genetic optimisation for e.coli expression
    1. Optimising protein expression
    2. Optimising purification
  • Optimising protein expression
    • Protease deficient strain (increases protein yield)
    • Promoter optimisation (inducibility, expression level)
    • Codon usage optimisation (improves translation rate)
    • PolyA signal (promotes mRNA stability, protection from endonucleases)
    • Selection marker (increases template number)
    • Replication origin (increases plasmid copies per cell)
    • N-terminal fusions (promotes protein stability)
  • Optimising purification
    • Fusion tags (affinity purification)
    • Signal peptides (secretion)
    • Chaperone co-expression (solubility)
  • Expression plasmid design

    • Promoter (for transcription)
    • Ribosome binding sequence (for translation)
    • N-terminal fusion (optional)
    • Signal peptide for secretion (optional)
    • Cloning site (for cDNA insertion)
    • Fusion tag for purification (optional)
    • Transcription terminator
    • PolyA signal (mRNA stability)
    • Chaperone-encoding gene (optional)
    • Selection gene (often antibiotic resistance)
    • Replication origin (controls copy number)
  • Lac operon
    Lacl produces a mRNA that becomes a proton that binds to operator that stops activation
  • Lac promotor
    • Protein expressed only when analogue of lactose added (ex: IPTG)
    • Expression products can be toxic, amplifying bacteria before expressing cDNA increases yield
  • Codon usage optimizationto improve translationation rate

    Genetic code degeneracy leads to species-specific codon bias, some amino acids are used more than others in E. coli
  • Means of optimising codon usage
    • Changing of one nucleotide base to change amino acid because it is better for e.coli
  • describe incorporating N- terminal fusion

    Can improve translation rate, increase protein stability, facilitate purification